Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.21.2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Sep. 30, 2019 $ 555 $ 9,594,100 $ (12,440,142) $ (2,845,487)
Balance, shares at Sep. 30, 2019 5,547,643      
Sale of common stock, net of issuance costs $ 13 2,715,017 2,715,030
Sale of common stock, net of issuance costs. shares 128,313      
Issuance of common stock to settle related-party notes $ 1 199,999 200,000
Issuance of common stock to settle related-party notes, shares 8,526      
Net loss (2,469,054) (2,469,054)
Balance at Dec. 31, 2019 $ 569 12,509,116 (14,909,196) (2,399,511)
Balance, shares at Dec. 31, 2019 5,684,482      
Balance at Sep. 30, 2019 $ 555 9,594,100 (12,440,142) (2,845,487)
Balance, shares at Sep. 30, 2019 5,547,643      
Net loss       (16,744,851)
Balance at Jun. 30, 2020 $ 920 29,563,893 (29,184,993) 379,820
Balance, shares at Jun. 30, 2020 9,200,176      
Balance at Dec. 31, 2019 $ 569 12,509,116 (14,909,196) (2,399,511)
Balance, shares at Dec. 31, 2019 5,684,482      
Sale of common stock, net of issuance costs $ 5 1,354,995 1,355,000
Sale of common stock, net of issuance costs. shares 57,762      
Net loss (2,496,747) (2,496,747)
Balance at Mar. 31, 2020 $ 574 13,864,111 (17,405,943) (3,541,258)
Balance, shares at Mar. 31, 2020 5,742,244      
Sale of common stock and warrants $ 215 14,999,785 15,000,000
Sale of common stock and warrants shares 2,152,360      
Issuance of common stock to affect the Relief acquisition $ 76 6,700,052 6,700,128
Issuance of common stock to affect the Relief acquisition, shares 757,933      
Issuance of common stock in connection with Merger (Note 3) $ 55 (6,000,055) (6,000,000)
Issuance of common stock and payment made in connection with Merger (Note 3), shares 547,639      
Net loss (11,779,050) (11,779,050)
Balance at Jun. 30, 2020 $ 920 29,563,893 (29,184,993) 379,820
Balance, shares at Jun. 30, 2020 9,200,176      
Balance at Sep. 30, 2020 $ 1,472 39,723,702 (36,705,257) 3,019,917
Balance, shares at Sep. 30, 2020 14,724,105      
Warrant exercises $ 2 2
Warrant exercises, shares 23,863      
Net share settlement of warrants $ 243 (243)
Net share settlement of warrants, shares 2,427,761      
Share-based compensation 370,055 370,055
Net loss (5,877,240) (5,877,240)
Balance at Dec. 31, 2020 $ 1,717 40,093,514 (42,582,497) (2,487,266)
Balance, shares at Dec. 31, 2020 17,175,729      
Balance at Sep. 30, 2020 $ 1,472 39,723,702 (36,705,257) 3,019,917
Balance, shares at Sep. 30, 2020 14,724,105      
Net loss       (18,031,888)
Balance at Jun. 30, 2021 $ 2,475 56,103,306 (54,737,145) 1,368,636
Balance, shares at Jun. 30, 2021 24,757,847      
Balance at Dec. 31, 2020 $ 1,717 40,093,514 (42,582,497) (2,487,266)
Balance, shares at Dec. 31, 2020 17,175,729      
Sale of common stock, net of issuance costs $ 402 10,178,225 10,178,627
Sale of common stock, net of issuance costs. shares 4,021,561      
Share-based compensation 370,055 370,055
Net loss (6,039,107) (6,039,107)
Balance at Mar. 31, 2021 $ 2,119 50,641,794 (48,621,604) 2,022,309
Balance, shares at Mar. 31, 2021 21,197,290      
Sale of common stock, net of issuance costs $ 343 5,143,869 5,144,212
Sale of common stock, net of issuance costs. shares 3,432,677      
Issuance of common stock on vesting of restricted stock units $ 13 (13)
Issuance of common stock on vetsing of restricted stock units 127,880      
Share-based compensation 317,656 317,656
Net loss (6,115,541) (6,115,541)
Balance at Jun. 30, 2021 $ 2,475 $ 56,103,306 $ (54,737,145) $ 1,368,636
Balance, shares at Jun. 30, 2021 24,757,847